Skandinaviska Enskilda Banken AB publ Grows Position in Veeva Systems Inc. $VEEV

Skandinaviska Enskilda Banken AB publ increased its holdings in Veeva Systems Inc. (NYSE:VEEV) by 21.5% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 266,571 shares of the technology company’s stock after purchasing an additional 47,151 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Veeva Systems were worth $76,767,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Sigma Planning Corp grew its stake in shares of Veeva Systems by 1.2% in the second quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock worth $958,000 after acquiring an additional 39 shares during the period. Keybank National Association OH lifted its position in Veeva Systems by 1.4% during the second quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock valued at $889,000 after purchasing an additional 42 shares during the period. Facet Wealth Inc. boosted its holdings in Veeva Systems by 3.3% in the second quarter. Facet Wealth Inc. now owns 1,342 shares of the technology company’s stock worth $381,000 after purchasing an additional 43 shares during the last quarter. TFB Advisors LLC grew its position in Veeva Systems by 1.2% in the 1st quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock worth $831,000 after purchasing an additional 44 shares during the period. Finally, Triangle Securities Wealth Management raised its stake in Veeva Systems by 0.8% during the 2nd quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock valued at $1,665,000 after buying an additional 45 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Buying and Selling at Veeva Systems

In related news, insider Thomas D. Schwenger sold 3,350 shares of Veeva Systems stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the sale, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This trade represents a 12.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jonathan Faddis sold 720 shares of the company’s stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $298.12, for a total value of $214,646.40. Following the completion of the transaction, the senior vice president owned 7,868 shares of the company’s stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 24,665 shares of company stock valued at $7,438,000 over the last ninety days. 10.30% of the stock is currently owned by company insiders.

Veeva Systems Trading Up 0.4%

NYSE VEEV opened at $240.79 on Friday. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50. The stock has a market cap of $39.47 billion, a price-to-earnings ratio of 49.44, a PEG ratio of 2.22 and a beta of 0.98. The company’s 50 day moving average is $284.83 and its two-hundred day moving average is $278.60.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.09. The firm had revenue of $811.24 million during the quarter, compared to analysts’ expectations of $792.37 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The company’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS. Q4 2026 guidance at 1.920-1.920 EPS. Sell-side analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Weiss Ratings upgraded Veeva Systems from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. JPMorgan Chase & Co. raised Veeva Systems from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $290.00 to $330.00 in a research report on Monday, September 8th. Robert W. Baird upped their price target on shares of Veeva Systems from $314.00 to $319.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. BTIG Research reiterated a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a research note on Friday, November 21st. Finally, Wells Fargo & Company cut their target price on shares of Veeva Systems from $341.00 to $333.00 and set an “overweight” rating for the company in a research report on Tuesday. Twenty analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $305.88.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.